SCHEMBL457249

SCHEMBL457249

Cc1cc(OBOc2ccc(C(=O)NC3CC3)c(C)c2)ccc1C(=O)NC1CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.48
NPC1 O15118 5/20 0.48
KMT2A Q03164 2/20 0.47
TAS1R3 Q7RTX0 1/20 0.47
TAS1R1 Q7RTX1 1/20 0.47
TAS1R2 Q8TE23 1/20 0.47
CNR1 P21554 2/20 0.44
CNR2 P34972 2/20 0.44
HPGD P15428 2/20 0.43
HRH3 Q9Y5N1 1/20 0.43
ALDH1A1 P00352 2/20 0.42
POLB P06746 1/20 0.42
MAPK14 Q16539 1/20 0.42
HTR4 Q13639 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9938205 0.83 HPGD (0.61) RAB9ANPC1KMT2ATAS1R3TAS1R1
SCHEMBL2319509 0.79 RAB9A (0.56) RAB9ANPC1KMT2AHPGDHRH3
SCHEMBL178430 0.79 TAS1R3 (0.66) RAB9ANPC1KMT2ATAS1R3TAS1R1
SCHEMBL15341542 0.77 NPC1 (0.54) RAB9ANPC1KMT2ATAS1R3TAS1R1
SCHEMBL29798407 0.77 HPGDS (0.57) RAB9ANPC1KMT2ACNR1CNR2
SCHEMBL13162029 0.77 HPGDS (0.57) RAB9ANPC1KMT2ACNR1CNR2
SCHEMBL455691 0.76 RAB9A (0.53) RAB9ANPC1KMT2ATAS1R3TAS1R1
SCHEMBL3233932 0.76 NPC1 (0.53) RAB9ANPC1TAS1R3TAS1R1TAS1R2
SCHEMBL516908 0.75 KDM4E (0.45) HPGDALDH1A1POLBKDM4ESMN1; SMN2
SCHEMBL9115503 0.75 MAOA (0.54) KMT2AALDH1A1MEN1SMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2614063-A1 SUBSTITUTED IMIDAZOPYRIDAZINES Bayer Intellectual Property GmbH (DE) 2013-07-17 EP disclosed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO disclosed